LILRB2 and Parkinson disease: In contrast, for the remaining four sites (rs113020870/AGRN, rs6891966/HAVCR2, rs2452170/NTN5, and rs1761461/LILRB2), no statistical difference in genotype or allele frequency was noted between AD, PD, and PDD patients, and the control group.